Next-generation probiotics (NGPs) have been widely investigated as a treatment modality for gastrointestinal disorders. With extensive expertise in the human probiotic field, Creative Biolabs is committed to deepening our understanding of the role of microbiota in human health aided by our next-generation sequencing and analytic tools, experimental technologies, and animal models. We have explored a live biotherapeutics discovery platform for NGP development, pre-clinical studies, and cGMP manufacturing to address different demands for pre-clinical, clinical, and commercial applications. Learn more: live biotherapeutics drug discovery services for gastrointestinal disorders